Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00519935 · ClinicalTrials.gov registry record · NA

Testing MST to Improve Adherence Among Youth With Chronic Poor Metabolic Control

A NA study of Type 1 Diabetes, sponsored by Wayne State University.

Completed
Registry status
NA
Development phase
127
Enrollment target
1
Study location

NCT00519935: Completed NA study of Type 1 Diabetes, sponsored by Wayne State University.

NCT00519935 is a NA study of Type 1 Diabetes that has completed, run by Wayne State University. The registered enrollment target is 127 participants, below the 766-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00519935, a NA study of Type 1 Diabetes, has completed, sponsored by Wayne State University.

COMPLETED
Registry status
NA
Development phase
127 participants
Enrollment target
1
Study location

Study Summary

The protocol is a randomized clinical trial providing Multisystemic Therapy (MST), an intensive home-based family psychotherapy intervention, to a group of urban adolescents with poorly controlled Type 1 diabetes and their families.

Primary Outcome

Retrospective measure of blood glucose control, encompasses the previous 2-3 months

Conditions Studied

Interventions

  • BEHAVIORAL Multisystemic Therapy

Study Locations (1)

Michigan

  • Children's Hospital of Michigan - Detroit

Trial Details

FieldValue
Enrollment Target 127 participants
Start Date 2001-07
Est. Completion 2006-03
Phase NA
Wayne State University

163 total trials

What the finished NCT00519935 record still lists

NCT00519935 is an interventional study that assigns participants to a tested intervention. The registered 127 participants enrollment target is mid-sized for trials with a published cap, below the 766-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (83% lower).

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Multisystemic Therapy is the first listed.

NCT00519935 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT00519935 about?

NCT00519935 is a clinical study titled "Testing MST to Improve Adherence Among Youth With Chronic Poor Metabolic Control". The protocol is a randomized clinical trial providing Multisystemic Therapy (MST), an intensive home-based family psychotherapy intervention, to a group of urban adolescents with poorly controlled Type 1 diabetes and their families.

What is the current status of trial NCT00519935?

This trial is currently completed. It is a NA study. The enrollment target is 127 participants. The study started on 2001-07. Estimated completion is 2006-03.

What conditions does trial NCT00519935 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

What interventions are being tested in trial NCT00519935?

The interventions under investigation include: Multisystemic Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00519935?

This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00519935 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00519935's enrollment target sits among peer trials

127 45th of 198 higher than 154 of 198 other Type 1 Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 1 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03017820 · 127 participants · Phase 1

    A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

  • NCT03609580 · 127 participants · Phase 1

    Post-operative Urinary Retention (POUR) Following Thoracic Surgery

  • NCT06285643 · 127 participants · Phase 2

    A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)

  • NCT06809400 · 127 participants · Phase 1

    A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00519935, the US trial registry maintained by the National Library of Medicine. NCT00519935 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.